Your browser doesn't support javascript.
loading
Body Mass Index and Mortality in Cardiogenic Shock.
Guglin, Maya; Zweck, Elric; Kanwar, Manreet; Sinha, Shashank S; Bhimaraj, Arvind; Li, Borui; Abraham, Jacob; Vallabhajosyula, Saraschandra; Hernandez-Montfort, Jaime; Kataria, Rachna; Burkhoff, Daniel; Kapur, Navin K.
Afiliación
  • Guglin M; From Department of Cardiology, the Indiana University Health, Indianapolis, Indiana.
  • Zweck E; Department of Cardiology, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Kanwar M; Department of Cardiology, The CardioVascular Center, Tufts Medical Center, Boston, Massachusetts.
  • Sinha SS; Department of Cardiology, Cardiovascular Institute at Allegheny Health Network, Pittsburgh, Pennsylvania.
  • Bhimaraj A; Department of Cardiology, Inova Heart and Vascular Institute, Inova Fairfax Campus, Falls Church, Virginia.
  • Li B; Department of Cardiology, Houston Methodist Research Institute, Houston, Texas.
  • Abraham J; Department of Cardiology, The CardioVascular Center, Tufts Medical Center, Boston, Massachusetts.
  • Vallabhajosyula S; Department of Cardiology, Providence Heart Institute, Portland, Oregon.
  • Hernandez-Montfort J; Department of Cardiology, Brown University, Providence, Rhode Island.
  • Kataria R; Department of Cardiology, Baylor Scott & White Health, Advanced Heart Failure Program Clinic, Temple, Texas.
  • Burkhoff D; Department of Cardiology, Brown University, Providence, Rhode Island.
  • Kapur NK; Department of Cardiology, Massachusetts General Hospital, Boston, Massachusetts.
ASAIO J ; 2024 Mar 25.
Article en En | MEDLINE | ID: mdl-38527077
ABSTRACT
We explored the association of body mass index (BMI) with mortality in cardiogenic shock (CS). Using the Cardiogenic Shock Working Group registry, we assessed the impact of BMI on mortality using restricted cubic splines in a multivariable logistic regression model adjusting for age, gender, and race. We also assessed mortality, device use, and complications in BMI categories, defined as underweight (<18.5 kg/m2), normal (18.5-24.9 kg/m2), overweight (25-29.9 kg/m2), obese (30-39.9 kg/m2), and severely obese (>40 kg/m2) using univariable logistic regression models. Our cohort had 3,492 patients with CS (mean age = 62.1 ± 14 years, 69% male), 58.0% HF-related CS (HF-CS), and 27.8% acute myocardial infarction (AMI) related CS. Body mass index was a significant predictor of mortality in multivariable regression using restricted cubic splines (p < 0.0001, p = 0.194 for nonlinearity). When stratified by categories, patients with healthy weight had lower mortality (29.0%) than obese (35.1%, p = 0.003) or severely obese (36.7%, p = 0.01). In HF-CS cohort, the healthy weight patients had the lowest mortality (21.7%), whereas it was higher in the underweight (37.5%, p = 0.012), obese (29.2%, p = 0.003), and severely obese (29.9%, p = 0.019). There was no difference in mortality among BMI categories in AMI-CS.

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: ASAIO J Asunto de la revista: TRANSPLANTE Año: 2024 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: ASAIO J Asunto de la revista: TRANSPLANTE Año: 2024 Tipo del documento: Article